Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Bolt Biotherapeutics, Inc.

NASDAQ: BOLT · Life Sciences · 8 alerts · CIK 1641281

Share price
$5.80Close, Nov 16
Market cap
$15.1M
Shares outstanding
2.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Bolt Biotherapeutics, Inc. filings on SEC EDGAR ↗

10:32 AM ET 8-K
M&A Deal

Bolt Biotherapeutics M&A Deal with Prana Therapies, Inc.

Bolt Biotherapeutics acquired Prana Therapies in a stock-for-stock reverse merger, issuing common and Series D preferred stock to Prana shareholders. Following the merger and a concurrent $120 million private placement, former Prana equityholders will own approximately 51.7% of the combined company. The transaction shifts Bolt's focus to Prana's INSPIRE platform and its lead bispecific antibody candidate, PRA-216, for inflammatory diseases.

Counterparty
Prana Therapies, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.